NOD-like receptors and inflammation

Arthritis Research and Therapy

Volumn 10, Issue 6, 2008, Pages

  Mathews, Rebeccah J ^a   Sprakes, Michael B ^b   McDermott, Michael F ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; BINDING PROTEIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; GENE PRODUCT; IMMUNOGLOBULIN D; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLIXIMAB; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MARENOSTRIN; MEVALONATE KINASE; NUCLEOTIDE BINDING AND OLIGOMERIZATION DOMAIN LEUCINE RICH REPEAT PROTEIN; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RILONACEPT; UNCLASSIFIED DRUG; AUTACOID; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN;

ASTHMA; BACTERIAL CELL WALL; BEHCET DISEASE; BLAU SYNDROME; CELL NUCLEUS; CELL STRESS; CINCA SYNDROME; CROHN DISEASE; CYTOKINE PRODUCTION; FAMILIAL COLD AUTOINFLAMMATORY SYNDROME; FAMILIAL MEDITERRANEAN FEVER; GENE MUTATION; GOUT; HUMAN; HYDATIDIFORM MOLE; HYPERIMMUNOGLOBULINEMIA D AND PERIODIC FEVER SYNDROME; HYPERTENSION; INFLAMMATION; INNATE IMMUNITY; JUVENILE RHEUMATOID ARTHRITIS; MOLECULAR RECOGNITION; MUCKLE WELLS SYNDROME; NONHUMAN; PAPA SYNDROME; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN TARGETING; PROTEIN TRANSPORT; PSEUDOGOUT; REVIEW; SARCOIDOSIS; SCHNITZLER SYNDROME; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; ULCERATIVE COLITIS; UPREGULATION; VITILIGO; ANIMAL; GENETICS; IMMUNOLOGY; METABOLISM; MUTATION; PHYSIOLOGY;

ANIMALS; HUMANS; INFLAMMATION MEDIATORS; MUTATION; NOD SIGNALING ADAPTOR PROTEINS; SIGNAL TRANSDUCTION;

EID: 57449105399     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2525     Document Type: Review

References (175)

1. Smith DE Renshaw BR Ketchem RR Kubin M Garka KE Sims JE Four new members expand the interleukin-1 superfamily J Biol Chem 2000, 275:1169-1175. 10.1074/jbc.275.2.1169 10625660
2. Schmitz J Owyang A Oldham E Song Y Murphy E McClanahan TK Zurawski G Moshrefi M Qin J Li X IL-33, an inter-leukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines Immunity 2005, 23:479-490. 10.1016/ j.immuni.2005.09.015 16286016
3. Dinarello CA Biologic basis for interleukin-1 in disease Blood 1996, 87:2095-2147. 8630372
4. Dinarello CA Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process Am J Clin Nutr 2006, 83:447S-455S. 16470011
5. Janeway CA Jr Medzhitov R Innate immune recognition Annu Rev Immunol 2002, 20:197-216. 10.1146/annurev.immunol.20.083001.084359 11861602
6. Medzhitov R Janeway CA Jr Innate immunity: Impact on the adaptive immune response Curr Opin Immunol 1997, 9:4-9. 10.1016/S0952-7915(97)80152-5 9039775
7. Poltorak A Smirnova I He X Liu MY Van Huffel C McNally O Birdwell D Alejos E Silva M Du X Thompson P Chan EK Ledesma J Roe B Clifton S Vogel SN Beutler B Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region Blood Cells Mol Dis 1998, 24:340-355. 10.1006/ bcmd.1998.0201 10087992
8. Gazzinelli RT Denkers EY Protozoan encounters with Toll-like receptor signalling pathways: Implications for host parasitism Nat Rev Immunol 2006, 6:895-906. 10.1038/nri1978 17110955
9. Trinchieri G Sher A Cooperation of Toll-like receptor signals in innate immune defence Nat Rev Immunol 2007, 7:179-190. 10.1038/nri2038 17318230
10. Akira S Uematsu S Takeuchi O Pathogen recognition and innate immunity Cell 2006, 124:783-801. 10.1016/j.cell.2006.02.015 16497588
11. HUGO: Nucleotide-binding domain and leucine rich repeat containing family http://www.genenames.org/genefamily/nlr.php
12. Fritz JH Ferrero RL Philpott DJ Girardin SE Nod-like proteins in immunity, inflammation and disease Nat Immunol 2006, 7:1250-1257. 10.1038/ni1412 17110941
13. Sirard JC Vignal C Dessein R Chamaillard M Nod-like receptors: Cytosolic watchdogs for immunity against pathogens PLoS Pathog 2007, 3:e152. 2156082 18166077 10.1371/journal.ppat.0030152
14. Sutterwala FS Mijares LA Li L Ogura Y Kazmierczak BI Flavell RA Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome J Exp Med 2007, 204:3235-3245. 2150987 18070936 10.1084/ jem.20071239
15. Tattoli I Travassos LH Carneiro LA Magalhaes JG Girardin SE The Nodosome: Nod1 and Nod2 control bacterial infections and inflammation Semin Immunopathol 2007, 29:289-301. 10.1007/s00281-007-0083-2 17690884
16. Martinon F Burns K Tschopp J The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-beta Mol Cell 2002, 10:417-426. 10.1016/S1097-2765(02)00599-3 12191486
17. Mariathasan S Newton K Monack DM Vucic D French DM Lee WP Roose-Girma M Erickson S Dixit VM Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf Nature 2004, 430:213-218. 10.1038/ nature02664 15190255
18. Faustin B Lartigue L Bruey JM Luciano F Sergienko E Bailly-Maitre B Volkmann N Hanein D Rouiller I Reed JC Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation Mol Cell 2007, 25:713-724. 10.1016/j.molcel.2007.01.032 17349957
19. Steinman L Therapy of autoimmune disease with monoclonal antibodies to class II gene products of the major histocompatibility complex Prog Allergy 1988, 45:161-167. 3217425
20. McDermott MF Aksentijevich I Galon J McDermott EM Ogunkolade BW Centola M Mansfield E Gadina M Karenko L Pettersson T McCarthy J Frucht DM Aringer M Torosyan Y Teppo AM Wilson M Karaarslan HM Wan Y Todd I Wood G Schlimgen R Kumarajeewa TR Cooper SM Vella JP Amos CI Mulley J Quane KA Molloy MG Ranki A Powell RJ Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes Cell 1999, 97:133-144. 10.1016/ S0092-8674(00)80721-7 10199409
21. Ting JP Kastner DL Hoffman HM CATERPILLERs, pyrin and hereditary immunological disorders Nat Rev Immunol 2006, 6:183-195. 10.1038/nri1788 16498449
22. Martinon F Tschopp J Inflammatory caspases and inflammasomes: Master switches of inflammation Cell Death Differ 2007, 14:10-22. 10.1038/ sj.cdd.4402038 16977329
23. Chu ZL Pio F Xie Z Welsh K Krajewska M Krajewski S Godzik A Reed JC A novel enhancer of the Apaf1 apoptosome involved in cytochrome c-dependent caspase activation and apoptosis J Biol Chem 2001, 276:9239-9245. 10.1074/jbc.M006309200 11113115
24. Hlaing T Guo RF Dilley KA Loussia JM Morrish TA Shi MM Vincenz C Ward PA Molecular cloning and characterization of DEFCAP-L and -S, two isoforms of a novel member of the mammalian Ced-4 family of apoptosis proteins J Biol Chem 2001, 276:9230-9238. 10.1074/jbc.M009853200 11076957
25. Petrilli V Papin S Tschopp J The inflammasome Curr Biol 2005, 15:R581. 10.1016/j.cub.2005.07.049 16085473
26. Bruey JM Bruey-Sedano N Luciano F Zhai D Balpai R Xu C Kress CL Bailly-Maitre B Li X Osterman A Matsuzawa S Terskikh AV Faustin B Reed JC Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1 Cell 2007, 129:45-56. 10.1016/j.cell.2007.01.045 17418785
27. Kummer JA Broekhuizen R Everett H Agostini L Kuijk L Martinon F van Bruggen R Tschopp J Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response J Histochem Cytochem 2007, 55:443-452. 10.1369/jhc.6A7101.2006 17164409
28. Jin Y Birlea SA Fain PR Spritz RA Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population J Invest Dermatol 2007, 127:2558-2562. 10.1038/sj.jid.5700953 17637824
29. Liu F Lo CF Ning X Kajkowski EM Jin M Chiriac C Gonzales C Naureckiene S Lock YW Pong K Zaleska MM Jacobsen JS Silverman S Ozenberger BA Expression of NALP1 in cerebellar granule neurons stimulates apoptosis Cell Signal 2004, 16:1013-1021. 15212762
30. Martinon F Agostini L Meylan E Tschopp J Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome Curr Biol 2004, 14:1929-1934. 10.1016/j.cub.2004.10.027 15530394
31. Solle M Labasi J Perregaux DG Stam E Petrushova N Koller BH Griffiths RJ Gabel CA Altered cytokine production in mice lacking P2X(7) receptors J Biol Chem 2001, 276:125-132. 10.1074/jbc.M006781200 11016935
32. Petrilli V Papin S Dostert C Mayor A Martinon F Tschopp J Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration Cell Death Differ 2007, 14:1583-1589. 10.1038/ sj.cdd.4402195 17599094
33. Perregaux D Barberia J Lanzetti AJ Geoghegan KF Carty TJ Gabel CA IL-1 beta maturation: Evidence that mature cytokine formation can be induced specifically by nigericin J Immunol 1992, 149:1294-1303. 1500719
34. Muruve DA Petrilli V Zaiss AK White LR Clark SA Ross PJ Parks RJ Tschopp J The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response Nature 2008, 452:103-107. 10.1038/ nature06664 18288107
35. Hornung V Bauernfeind F Halle A Samstad EO Kono H Rock KL Fitzgerald KA Latz E Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization Nat Immunol 2008, 9:847-856. 10.1038/ni.1631 18604214
36. Cassel SL Eisenbarth SC Iyer SS Sadler JJ Colegio OR Tephly LA Carter AB Rothman PB Flavell RA Sutterwala FS The Nalp3 inflammasome is essential for the development of silicosis Proc Natl Acad Sci USA 2008, 105:9035-9040. 10.1073/pnas.0803933105 18577586
37. Dostert C Petrilli V Van Bruggen R Steele C Mossman BT Tschopp J Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica Science 2008, 320:674-677. 2396588 18403674 10.1126/ science.1156995
38. Hoffman HM Wanderer AA Broide DH Familial cold auto-inflammatory syndrome: Phenotype and genotype of an autosomal dominant periodic fever J Allergy Clin Immunol 2001, 108:615-620. 10.1067/mai.2001.118790 11590390
39. Feldmann J Prieur AM Quartier P Berquin P Certain S Cortis E Teillac-Hamel D Fischer A de Saint Basile G Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes Am J Hum Genet 2002, 71:198-203. 384980 12032915 10.1086/ 341357
40. Dowds TA Masumoto J Zhu L Inohara N Nunez G Cryopyrin-induced interleukin 1beta secretion in monocytic cells: Enhanced activity of disease-associated mutants and requirement for ASC J Biol Chem 2004, 279:21924-21928. 10.1074/jbc.M401178200 15020601
41. Tschopp J Martinon F Burns K NALPs: A novel protein family involved in inflammation Nat Rev Mol Cell Biol 2003, 4:95-104. 10.1038/nrm1019 12563287
42. Aksentijevich I D Putnam C Remmers EF Mueller JL Le J Kolodner RD Moak Z Chuang M Austin F Goldbach-Mansky R Hoffman HM Kastner DL The clinical continuum of cryopyrinopathies: Novel CIAS1 mutations in North American patients and a new cryopyrin model Arthritis Rheum 2007, 56:1273-1285. 10.1002/art.22491 17393462
43. Aksentijevich I Nowak M Mallah M Chae JJ Watford WT Hofmann SR Stein L Russo R Goldsmith D Dent P Rosenberg HF Austin F Remmers EF Balow JE Jr Rosenzweig S Komarow H Shoham NG Wood G Jones J Mangra N Carrero H Adams BS Moore TL Schikler K Hoffman H Lovell DJ Lipnick R Barron K O'Shea JJ Kastner DL De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): A new member of the expanding family of pyrin-associated autoinflammatory diseases Arthritis Rheum 2002, 46:3340-3348. 10.1002/art.10688 12483741
44. Agostini L Martinon F Burns K McDermott MF Hawkins PN Tschopp J NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder Immunity 2004, 20:319-325. 10.1016/S1074-7613(04)00046-9 15030775
45. Janssen R Verhard E Lankester A Ten Cate R van Dissel JT Enhanced interleukin-1beta and interleukin-18 release in a patient with chronic infantile neurologic, cutaneous, articular syndrome Arthritis Rheum 2004, 50:3329-3333. 10.1002/art.20494 15476236
46. Takada H Ishimura M Inada H Ohga S Kusuhara K Moroi Y Furue M Hara T Lipopolysaccharide-induced monocytic cell death for the diagnosis of mild neonatal-onset multisystem inflammatory disease J Pediatr 2008, 152:885-887. 10.1016/j.jpeds.2008.01.038 18492537
47. Dowds TA Masumoto J Chen FF Ogura Y Inohara N Nunez G Regulation of cryopyrin/Pypaf1 signaling by pyrin, the familial Mediterranean fever gene product Biochem Biophys Res Commun 2003, 302:575-580. 10.1016/ S0006-291X(03)00221-3 12615073
48. Stojanov S Kastner DL Familial autoinflammatory diseases: Genetics, pathogenesis and treatment Curr Opin Rheumatol 2005, 17:586-599. 10.1097/ bor.0000174210.78449.6b 16093838
49. Wise CA Gillum JD Seidman CE Lindor NM Veile R Bashiardes S Lovett M Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder Hum Mol Genet 2002, 11:961-969. 10.1093/hmg/11.8.961 11971877
50. McDermott MF A common pathway in periodic fever syndromes Trends Immunol 2004, 25:457-460. 10.1016/j.it.2004.07.007 15324736
51. Day TG Ramanan AV Hinks A Lamb R Packham J Wise C Punaro M Donn RP Autoinflammatory genes and susceptibility to psoriatic juvenile idiopathic arthritis Arthritis Rheum 2008, 58:2142-2146. 10.1002/ art.23604 18576390
52. Giaglis S Mimidis K Papadopoulos V Thomopoulos K Sidiropoulos P Rafail S Nikolopoulou V Fragouli E Kartalis G Tzioufas A Boumpas D Ritis K Increased frequency of mutations in the gene responsible for familial Mediterranean fever (MEFV) in a cohort of patients with ulcerative colitis: Evidence for a potential disease-modifying effect? Dig Dis Sci 2006, 51:687-692. 10.1007/s10620-006-3192-1 16614989
53. Sari S Egritas O Dalgic B The familial Mediterranean fever (MEFV) gene may be a modifier factor of inflammatory bowel disease in infancy Eur J Pediatr 2008, 167:391-393. 10.1007/s00431-007-0508-x 17520284
54. Omi T Kumada M Kamesaki T Okuda H Munkhtulga L Yanagisawa Y Utsumi N Gotoh T Hata A Soma M Umemura S Ogihara T Takahashi N Tabara Y Shimada K Mano H Kajii E Miki T Iwamoto S An intronic variable number of tandem repeat polymorphisms of the cold-induced autoinflammatory syndrome 1 (CIAS1) gene modifies gene expression and is associated with essential hypertension Eur J Hum Genet 2006, 14:1295-1305. 10.1038/sj.ejhg.5201698 16868559
55. Rosengren S Hoffman HM Bugbee W Boyle DL Expression and regulation of cryopyrin and related proteins in rheumatoid arthritis synovium Ann Rheum Dis 2005, 64:708-714. 1755498 15498798 10.1136/ard.2004.025577
56. Mahr S Burmester GR Hilke D Göbel U Grützkau A Häupl T Hauschild M Koczan D Krenn V Neidel J Perka C Radbruch A Thiesen HJ Müller B Cis- and trans-acting gene regulation is associated with osteoarthritis Am J Hum Genet 2006, 78:793-803. 1474041 16642435 10.1086/ 503849
57. Martinon F Petrilli V Mayor A Tardivel A Tschopp J Gout-associated uric acid crystals activate the NALP3 inflammasome Nature 2006, 440:237-241. 10.1038/nature04516 16407889
58. So A De Smedt T Revaz S Tschopp J A pilot study of IL-1 inhibition by anakinra in acute gout Arthritis Res Ther 2007, 9:R28. 1906806 17352828 10.1186/ar2143
59. McGonagle D Tan AL Shankaranarayana S Madden J Emery P McDermott MF Management of treatment resistant inflammation of acute on chronic tophaceous gout with anakinra Ann Rheum Dis 2007, 66:1683-1684. 10.1136/ ard.2007.073759 17998217
60. McGonagle D Tan AL Madden J Emery P McDermott MF Successful treatment of resistant pseudogout with anakinra Arthritis Rheum 2008, 58:631-633. 10.1002/art.23119 18240249
61. Alexander T Klotz O Feist E Ruther K Burmester GR Pleyer U Successful treatment of acute visual loss in Muckle-Wells syndrome with interleukin 1 receptor antagonist Ann Rheum Dis 2005, 64:1245-1246. 1755588 16014694 10.1136/ard.2004.032060
62. Dalgic B Egritas O Sari S Cuisset L A variant Muckle-Wells syndrome with a novel mutation in CIAS1 gene responding to anakinra Pediatr Nephrol 2007, 22:1391-1394. 10.1007/s00467-007-0500-8 17486372
63. Gerard S le Goff B Maugars Y Berthelot JM Malard O Lasting remission of a Muckle-Wells syndrome with CIAS-1 mutation using half-dose anakinra Joint Bone Spine 2007, 74:659. 10.1016/j.jbspin.2007.01.032 17892965
64. Hawkins PN Lachmann HJ Aganna E McDermott MF Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra Arthritis Rheum 2004, 50:607-612. 10.1002/art.20033 14872505
65. Maksimovic L Stirnemann J Caux F Ravet N Rouaghe S Cuisset L Letellier E Grateau G Morin AS Fain O New CIAS1 mutation and anakinra efficacy in overlapping of Muckle-Wells and familial cold autoinflammatory syndromes Rheumatology (Oxford) 2008, 47:309-310. 10.1093/rheumatology/kem318 18174231
66. Mirault T Launay D Cuisset L Hachulla E Lambert M Queyrel V Quemeneur T Morell-Dubois S Hatron PY Recovery from deafness in a patient with Muckle-Wells syndrome treated with anakinra Arthritis Rheum 2006, 54:1697-1700. 10.1002/art.21807 16646042
67. Rynne M Maclean C Bybee A McDermott MF Emery P Hearing improvement in a patient with variant Muckle-Wells syndrome in response to interleukin 1 receptor antagonism Ann Rheum Dis 2006, 65:533-534. 10.1136/ ard.2005.038091 16531551
68. Yamazaki T Masumoto J Agematsu K Sawai N Kobayashi S Shigemura T Yasui K Koike K Anakinra improves sensory deafness in a Japanese patient with Muckle-Wells syndrome, possibly by inhibiting the cryopyrin inflammasome Arthritis Rheum 2008, 58:864-868. 10.1002/art.23261 18311804
69. Hoffman HM Rosengren S Boyle DL Cho JY Nayar J Mueller JL Anderson JP Wanderer AA Firestein GS Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist Lancet 2004, 364:1779-1785. 10.1016/ S0140-6736(04)17401-1 15541451
70. Metyas SK Hoffman HM Anakinra prevents symptoms of familial cold autoinflammatory syndrome and Raynaud's disease J Rheumatol 2006, 33:2085-2087. 16981288
71. O'Connell SM O'Regan GM Bolger T Hoffman HM Cant A Irvine AD Watson RM Response to IL-1-receptor antagonist in a child with familial cold autoinflammatory syndrome Pediatr Dermatol 2007, 24:85-89. 17300660
72. Ross JB Finlayson LA Klotz PJ Langley RG Gaudet R Thompson K Churchman SM McDermott MF Hawkins PN Use of anakinra (Kineret) in the treatment of familial cold autoinflammatory syndrome with a 16-month follow-up J Cutan Med Surg 2008, 12:8-16. 18258152
73. Thornton BD Hoffman HM Bhat A Don BR Successful treatment of renal amyloidosis due to familial cold autoinflammatory syndrome using an interleukin 1 receptor antagonist Am J Kidney Dis 2007, 49:477-481. 10.1053/j.ajkd.2006.10.026 17336710
74. Goldbach-Mansky R Dailey NJ Canna SW Gelabert A Jones J Rubin BI Kim HJ Brewer C Zalewski C Wiggs E Hill S Turner ML Karp BI Aksentijevich I Pucino F Penzak SR Haverkamp MH Stein L Adams BS Moore TL Fuhlbrigge RC Shaham B Jarvis JN O'Neil K Vehe RK Beitz LO Gardner G Hannan WP Warren RW Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition N Engl J Med 2006, 355:581-592. 10.1056/ NEJMoa055137 16899778
75. Goldbach-Mansky R Pucino F Kastner DL Treatment of patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome: Comment on the article by Matsubara et al Arthritis Rheum 2007, 56:2099-2101. author reply 2101-2092. 10.1002/art.22561 17530657
76. Lovell DJ Bowyer SL Solinger AM Interleukin-1 blockade by anakinra improves clinical symptoms in patients with neonatal-onset multisystem inflammatory disease Arthritis Rheum 2005, 52:1283-1286. 10.1002/ art.20953 15818707
77. de Koning HD Bodar EJ Simon A Hilst van der JC Netea MG Meer van der JW Beneficial response to anakinra and thalidomide in Schnitzler's syndrome Ann Rheum Dis 2006, 65:542-544. 10.1136/ard.2005.045245 16096327
78. Alten R Gram H Joosten LA Berg van den WB Sieper J Wassenberg S Burmester G van Riel P Diaz-Lorente M Bruin GJ Woodworth TG Rordorf C Batard Y Wright AM Jung T The human anti-interleukin-1b monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof of concept study in rheumatoid arthritis patients Arthritis Res Ther 2008, 10:R67. 2483458 18534016 10.1186/ar2438
79. Tomillero A Moral MA Gateways to clinical trials Methods Find Exp Clin Pharmacol 2008, 30:2310251. 18597009
80. Mathews R Churchman S Church L Coulthard L Byryer D Nizam S Saleem B Cook GP Emery P McDermott MF Effects of TNF blockade by infliximab on inflammasome regulators in rheumatoid arthritis patients [Abstract] Ann Rheum Dis 2008, 67(suppl 1):A25.
81. Karababa M Kolly L Tschopp J Busso N Crucial role of ASC-dependent inflammasome in murine arthritis [Abstract] Arthritis Rheum 2007, 56(suppl 1):1280.
82. Johansen C Moeller K Kragballe K Iversen L The activity of caspase-1 is increased in lesional psoriatic epidermis J Invest Dermatol 2007, 127:2857-2864. 17597823
83. Franchi L Stoolman J Kanneganti TD Verma A Ramphal R Nunez G Critical role for Ipaf in Pseudomonas aeruginosa-induced caspase-1 activation Eur J Immunol 2007, 37:3030-3039. 10.1002/eji.200737532 17935074
84. Franchi L Amer A Body-Malapel M Kanneganti TD Ozören N Jagirdar R Inohara N Vandenabeele P Bertin J Coyle A Grant EP Núñez G Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages Nat Immunol 2006, 7:576-582. 10.1038/ni1346 16648852
85. Amer A Franchi L Kanneganti TD Body-Malapel M Ozören N Brady G Meshinchi S Jagirdar R Gewirtz A Akira S Núñez G Regulation of Legionella phagosome maturation and infection through flagellin and host Ipaf J Biol Chem 2006, 281:35217-35223. 10.1074/jbc.M604933200 16984919
86. Jin Y Mailloux CM Gowan K Riccardi SL LaBerge G Bennett DC Fain PR Spritz RA NALP1 in vitiligo-associated multiple autoimmune disease N Engl J Med 2007, 356:1216-1225. 10.1056/NEJMoa061592 17377159
87. Murdoch S Djuric U Mazhar B Seoud M Khan R Kuick R Bagga R Kircheisen R Ao A Ratti B Hanash S Rouleau GA Slim R Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans Nat Genet 2006, 38:300-302. 10.1038/ng1740 16462743
88. Steimle V Otten LA Zufferey M Mach B Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome) Cell 1993, 75:135-146. 8402893
89. Martinez A Alvarez-Lafuente R Mas A Bartolome M Garcia-Montojo M de Las Heras V de la Concha EG Arroyo R Urcelay E Environment-gene interaction in multiple sclerosis: Human herpesvirus 6 and MHC2TA Hum Immunol 2007, 68:685-689. 10.1016/j.humimm.2007.05.005 17678724
90. Hugot JP Chamaillard M Zouali H Lesage S Cézard JP Belaiche J Almer S Tysk C O'Morain CA Gassull M Binder V Finkel Y Cortot A Modigliani R Laurent-Puig P Gower-Rousseau C Macry J Colombel JF Sahbatou M Thomas G Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease Nature 2001, 411:599-603. 10.1038/ 35079107 11385576
91. Miceli-Richard C Lesage S Rybojad M Prieur AM Manouvrier-Hanu S Hafner R Chamaillard M Zouali H Thomas G Hugot JP CARD15 mutations in Blau syndrome Nat Genet 2001, 29:19-20. 10.1038/ng720 11528384
92. McGonagle D Savic S McDermott MF The NLR network and the immunological disease continuum of adaptive and innate immune-mediated inflammation against self Semin Immunopathol 2007, 29:303-313. 10.1007/ s00281-007-0084-1 17805542
93. Suzuki T Franchi L Toma C Ashida H Ogawa M Yoshikawa Y Mimuro H Inohara N Sasakawa C Nunez G Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages PLoS Pathog 2007, 3:e111. 1941748 17696608 10.1371/ journal.ppat.0030111
94. Girardin SE Travassos LH Herve M Blanot D Boneca IG Philpott DJ Sansonetti PJ Mengin-Lecreulx D Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2 J Biol Chem 2003, 278:41702-41708. 10.1074/jbc.M307198200 12871942
95. Inohara N Koseki T del Peso L Hu Y Yee C Chen S Carrio R Merino J Liu D Ni J Ni J Núñez G Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB J Biol Chem 1999, 274:14560-14567. 10.1074/jbc.274.21.14560 10329646
96. Inohara N Koseki T Lin J del Peso L Lucas PC Chen FF Ogura Y Nunez G An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways J Biol Chem 2000, 275:27823-27831. 10880512
97. Abbott DW Wilkins A Asara JM Cantley LC The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO Curr Biol 2004, 14:2217-2227. 10.1016/j.cub.2004.12.032 15620648
98. Pan Q Mathison J Fearns C Kravchenko VV Da Silva Correia J Hoffman HM Kobayashi KS Bertin J Grant EP Coyle AJ Sutterwala FS Ogura Y Flavell RA Ulevitch RJ MDP-induced interleukin-1beta processing requires Nod2 and CIAS1/NALP3 J Leukoc Biol 2007, 82:177-183. 10.1189/jlb.1006627 17403772
99. Park JH Kim YG McDonald C Kanneganti TD Hasegawa M Body-Malapel M Inohara N Nunez G RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs J Immunol 2007, 178:2380-2386. 17277144
100. Yang Y Yin C Pandey A Abbott D Sassetti C Kelliher MA NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2 J Biol Chem 2007, 282:36223-36229. 10.1074/jbc.M703079200 17947236
101. Girardin SE Tournebize R Mavris M Page AL Li X Stark GR Bertin J DiStefano PS Yaniv M Sansonetti PJ Philpott DJ CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri EMBO Rep 2001, 2:736-742. 1083992 11463746 10.1093/embo-reports/kve155
102. Philpott DJ Yamaoka S Israel A Sansonetti PJ Invasive Shigella flexneri activates NF-kappa B through a lipopolysaccharide-dependent innate intracellular response and leads to IL-8 expression in epithelial cells J Immunol 2000, 165:903-914. 10878365
103. Kim JG Lee SJ Kagnoff MF Nod1 is an essential signal transducer in intestinal epithelial cells infected with bacteria that avoid recognition by toll-like receptors Infect Immun 2004, 72:1487-1495. 356064 14977954 10.1128/IAI.72.3.1487-1495.2004
104. Viala J Chaput C Boneca IG Cardona A Girardin SE Moran AP Athman R Mémet S Huerre MR Coyle AJ DiStefano PS Sansonetti PJ Labigne A Bertin J Philpott DJ Ferrero RL Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island Nat Immunol 2004, 5:1166-1174. 10.1038/ni1131 15489856
105. Fischer W Puls J Buhrdorf R Gebert B Odenbreit S Haas R Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8 Mol Microbiol 2001, 42:1337-1348. 10.1046/ j.1365-2958.2001.02714.x 11886563
106. Cascales E Christie PJ The versatile bacterial type IV secretion systems Nat Rev Microbiol 2003, 1:137-149. 10.1038/nrmicro753 15035043
107. Rosenstiel P Hellmig S Hampe J Ott S Till A Fischbach W Sahly H Lucius R Fölsch UR Philpott D Schreiber S Influence of polymorphisms in the NOD1/CARD4 and NOD2/CARD15 genes on the clinical outcome of Helicobacter pylori infection Cell Microbiol 2006, 8:1188-1198. 10.1111/ j.1462-5822.2006.00701.x 16819970
108. Zilbauer M Dorrell N Elmi A Lindley KJ Schuller S Jones HE Klein NJ Nunez G Wren BW Bajaj-Elliott M A major role for intestinal epithelial nucleotide oligomerization domain 1 (NOD1) in eliciting host bactericidal immune responses to Campylobacter jejuni Cell Microbiol 2007, 9:2404-2416. 10.1111/j.1462-5822.2007.00969.x 17521327
109. Travassos LH Carneiro LA Girardin SE Boneca IG Lemos R Bozza MT Domingues RC Coyle AJ Bertin J Philpott DJ Plotkowski MC Nod1 participates in the innate immune response to Pseudomonas aeruginosa J Biol Chem 2005, 280:36714-36718. 10.1074/jbc.M501649200 16150702
110. Welter-Stahl L Ojcius DM Viala J Girardin S Liu W Delarbre C Philpott D Kelly KA Darville T Stimulation of the cytosolic receptor for peptidoglycan, Nod1, by infection with Chlamydia trachomatis or Chlamydia muridarum Cell Microbiol 2006, 8:1047-1057. 10.1111/ j.1462-5822.2006.00686.x 16681844
111. Laitinen T Daly MJ Rioux JD Kauppi P Laprise C Petäys T Green T Cargill M Haahtela T Lander ES Laitinen LA Hudson TJ Kere J A susceptibility locus for asthma-related traits on chromosome 7 revealed by genome-wide scan in a founder population Nat Genet 2001, 28:87-91. 10.1038/88319 11326283
112. Weidinger S Klopp N Rummler L Wagenpfeil S Novak N Baurecht HJ Groer W Darsow U Heinrich J Gauger A Schafer T Jakob T Behrendt H Wichmann HE Ring J Illig T Association of NOD1 polymorphisms with atopic eczema and related phenotypes J Allergy Clin Immunol 2005, 116:177-184. 10.1016/ j.jaci.2005.02.034 15990792
113. Zouali H Lesage S Merlin F Cézard JP Colombel JF Belaiche J Almer S Tysk C O'Morain C Gassull M Christensen S Finkel Y Modigliani R Gower-Rousseau C Macry J Chamaillard M Thomas G Hugot JP EPWG group; EPIMAD group CARD4/NOD1 is not involved in inflammatory bowel disease Gut 2003, 52:71-74. 1773516 12477763 10.1136/gut.52.1.71
114. Van Limbergen J Nimmo ER Russell RK Drummond HE Smith L Anderson NH Davies G Arnott ID Wilson DC Satsangi J Investigation of NOD1/CARD4 variation in inflammatory bowel disease using a haplotype-tagging strategy Hum Mol Genet 2007, 16:2175-2186. 10.1093/hmg/ddm169 17613538
115. Tremelling M Hancock L Bredin F Sharpstone D Bingham SA Parkes M Complex insertion/deletion polymorphism in NOD1 (CARD4) is not associated with inflammatory bowel disease susceptibility in East Anglia panel Inflamm Bowel Dis 2006, 12:967-971. 10.1097/01.mib.0000234131.89971.e5 17012967
116. Coto-Segura P Mallo-Garcia S Costa-Romero M Arostegui JI Yague J Ramos-Polo E Santos-Juanes J A sporadic case of early-onset sarcoidosis resembling Blau syndrome due to the recurrent R334W missense mutation on the NOD2 gene Br J Dermatol 2007, 157:1257-1259. 10.1111/ j.1365-2133.2007.08210.x 17916199
117. Kanazawa N Matsushima S Kambe N Tachibana T Nagai S Miyachi Y Presence of a sporadic case of systemic granulomatosis syndrome with a CARD15 mutation J Invest Dermatol 2004, 122:851-852. 10.1111/ j.0022-202X.2004.22341.x 15086578
118. Ogura Y Bonen DK Inohara N Nicolae DL Chen FF Ramos R Britton H Moran T Karaliuskas R Duerr RH Achkar JP Brant SR Bayless TM Kirschner BS Hanauer SB Nuñez G Cho JH A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease Nature 2001, 411:603-606. 10.1038/ 35079114 11385577
119. Romagnani P Annunziato F Baccari MC Parronchi P T cells and cytokines in Crohn's disease Curr Opin Immunol 1997, 9:793-799. 10.1016/ S0952-7915(97)80180-X 9492980
120. Lesage S Zouali H Cézard JP Colombel JF Belaiche J Almer S Tysk C O'Morain C Gassull M Binder V Finkel Y Modigliani R Gower-Rousseau C Macry J Merlin F Chamaillard M Jannot AS Thomas G Hugot JP EPWG-IBD Group; EPIMAD Group; GETAID Group CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease Am J Hum Genet 2002, 70:845-857. 379113 11875755 10.1086/339432
121. Bonen DK Ogura Y Nicolae DL Inohara N Saab L Tanabe T Chen FF Foster SJ Duerr RH Brant SR Cho JH Nuñez G Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan Gastroenterology 2003, 124:140-146. 10.1053/ gast.2003.50019 12512038
122. Netea MG Ferwerda G de Jong DJ Girardin SE Kullberg BJ Meer van der JW NOD2 3020insC mutation and the pathogenesis of Crohn's disease: Impaired IL-1beta production points to a loss-of-function phenotype Neth J Med 2005, 63:305-308. 16186640
123. Ligumsky M Simon PL Karmeli F Rachmilewitz D Role of interleukin 1 in inflammatory bowel disease: Enhanced production during active disease Gut 1990, 31:686-689. 1378497 2379873 10.1136/gut.31.6.686
124. Mitsuyama K Sata M Tanikawa K Significance of interleukin-6 in patients with inflammatory bowel disease Gastroenterol Jpn 1991, 26:20-28. 2007457
125. Monteleone G Biancone L Marasco R Morrone G Marasco O Luzza F Pallone F Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells Gastroenterology 1997, 112:1169-1178. 10.1016/S0016-5085(97)70128-8 9098000
126. Watanabe T Kitani A Murray PJ Strober W NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses Nat Immunol 2004, 5:800-808. 10.1038/ni1092 15220916
127. Watanabe T Kitani A Murray PJ Wakatsuki Y Fuss IJ Strober W Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis Immunity 2006, 25:473-485. 10.1016/j.immuni.2006.06.018 16949315
128. Borm ME van Bodegraven AA Mulder CJ Kraal G Bouma G The effect of NOD2 activation on TLR2-mediated cytokine responses is dependent on activation dose and NOD2 genotype Genes Immun 2008, 9:274-278. 10.1038/ gene.2008.9 18340358
129. Kobayashi KS Chamaillard M Ogura Y Henegariu O Inohara N Nunez G Flavell RA Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract Science 2005, 307:731-734. 10.1126/science.1104911 15692051
130. Ouellette AJ Bevins CL Paneth cell defensins and innate immunity of the small bowel Inflamm Bowel Dis 2001, 7:43-50. 10.1097/ 00054725-200102000-00007 11233660
131. Ayabe T Satchell DP Wilson CL Parks WC Selsted ME Ouellette AJ Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria Nat Immunol 2000, 1:113-118. 10.1038/77783 11248802
132. Ogura Y Lala S Xin W Smith E Dowds TA Chen FF Zimmermann E Tretiakova M Cho JH Hart J Greenson JK Keshav S Nuñez G Expression of NOD2 in Paneth cells: A possible link to Crohn's ileitis Gut 2003, 52:1591-1597. 1773866 14570728 10.1136/gut.52.11.1591
133. Cuthbert AP Fisher SA Mirza MM King K Hampe J Croucher PJ Mascheretti S Sanderson J Forbes A Mansfield J Schreiber S Lewis CM Mathew CG The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease Gastroenterology 2002, 122:867-874. 10.1053/ gast.2002.32415 11910337
134. Hampe J Frenzel H Mirza MM Croucher PJ Cuthbert A Mascheretti S Huse K Platzer M Bridger S Meyer B Nürnberg P Stokkers P Krawczak M Mathew CG Curran M Schreiber S Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16p Proc Natl Acad Sci USA 2002, 99:321-326. 117559 11752413 10.1073/pnas.261567999
135. Wehkamp J Salzman NH Porter E Nuding S Weichenthal M Petras RE Shen B Schaeffeler E Schwab M Linzmeier R Feathers RW Chu H Lima H Jr Fellermann K Ganz T Stange EF Bevins CL Reduced Paneth cell alpha-defensins in ileal Crohn's disease Proc Natl Acad Sci USA 2005, 102:18129-18134. 1306791 16330776 10.1073/pnas.0505256102
136. Kramer M Netea MG de Jong DJ Kullberg BJ Adema GJ Impaired dendritic cell function in Crohn's disease patients with NOD2 3020insC mutation J Leukoc Biol 2006, 79:860-866. 10.1189/jlb.0805484 16461743
137. Hampe J Franke A Rosenstiel P Till A Teuber M Huse K Albrecht M Mayr G De La Vega FM Briggs J Günther S Prescott NJ Onnie CM Häsler R Sipos B Fölsch UR Lengauer T Platzer M Mathew CG Krawczak M Schreiber S A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1 Nat Genet 2007, 39:207-211. 10.1038/ng1954 17200669
138. Parkes M Barrett JC Prescott NJ Tremelling M Anderson CA Fisher SA Roberts RG Nimmo ER Cummings FR Soars D Drummond H Lees CW Khawaja SA Bagnall R Burke DA Todhunter CE Ahmad T Onnie CM McArdle W Strachan D Bethel G Bryan C Lewis CM Deloukas P Forbes A Sanderson J Jewell DP Satsangi J Mansfield JC Wellcome Trust Case Control Consortium Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility Nat Genet 2007, 39:830-832. 10.1038/ng2061 17554261
139. Tremelling M Cummings F Fisher SA Mansfield J Gwilliam R Keniry A Nimmo ER Drummond H Onnie CM Prescott NJ Sanderson J Bredin F Berzuini C Forbes A Lewis CM Cardon L Deloukas P Jewell D Mathew CG Parkes M Satsangi J IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease Gastroenterology 2007, 132:1657-1664. 10.1053/j.gastro.2007.02.051 17484863
140. Inoue N Tamura K Kinouchi Y Fukuda Y Takahashi S Ogura Y Inohara N Núñez G Kishi Y Koike Y Shimosegawa T Shimoyama T Hibi T Lack of common NOD2 variants in Japanese patients with Crohn's disease Gastroenterology 2002, 123:86-91. 10.1053/gast.2002.34155 12105836
141. Yamazaki K Takazoe M Tanaka T Kazumori T Nakamura Y Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease J Hum Genet 2002, 47:469-472. 10.1007/s100380200067 12202985
142. McGovern DP Van Heel DA Negoro K Ahmad T Jewell DP Further evidence of IBD5/CARD15 (NOD2) epistasis in the susceptibility to ulcerative colitis Am J Hum Genet 2003, 73:1465-1466. 1180410 14655097 10.1086/379745
143. Manouvrier-Hanu S Puech B Piette F Boute-Benejean O Desbonnet A Duquesnoy B Farriaux JP Blau syndrome of granulomatous arthritis, iritis, and skin rash: A new family and review of the literature Am J Med Genet 1998, 76:217-221. 10.1002/ (SICI)1096-8628(19980319)76:3<217::AID-AJMG4>3.0.CO;2-N 9508240
144. van Duist MM Albrecht M Podswiadek M Giachino D Lengauer T Punzi L De Marchi M A new CARD15 mutation in Blau syndrome Eur J Hum Genet 2005, 13:742-747. 10.1038/sj.ejhg.5201404 15812565
145. Chamaillard M Philpott D Girardin SE Zouali H Lesage S Chareyre F Bui TH Giovannini M Zaehringer U Penard-Lacronique V Sansonetti PJ Hugot JP Thomas G Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases Proc Natl Acad Sci USA 2003, 100:3455-3460. 152314 12626759 10.1073/pnas.0530276100
146. Kanazawa N Okafuji I Kambe N Nishikomori R Nakata-Hizume M Nagai S Fuji A Yuasa T Manki A Sakurai Y Nakajima M Kobayashi H Fujiwara I Tsutsumi H Utani A Nishigori C Heike T Nakahata T Miyachi Y Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome Blood 2005, 105:1195-1197. 10.1182/blood-2004-07-2972 15459013
147. Schurmann M Valentonyte R Hampe J Muller-Quernheim J Schwinger E Schreiber S CARD15 gene mutations in sarcoidosis Eur Respir J 2003, 22:748-754. 10.1183/09031936.03.00040602 14621080
148. Newman B Rubin LA Siminovitch KA NOD2/CARD15 gene mutation is not associated with susceptibility to Wegener's granulomatosis J Rheumatol 2003, 30:305-307. 12563685
149. Brenmoehl J Herfarth H Glück T Audebert F Barlage S Schmitz G Froehlich D Schreiber S Hampe J Schölmerich J Holler E Rogler G Genetic variants in the NOD2/CARD15 gene are associated with early mortality in sepsis patients Intensive Care Med 2007, 33:1541-1548. 10.1007/s00134-007-0722-z 17558494
150. Holler E Rogler G Herfarth H Brenmoehl J Wild PJ Hahn J Eissner G Scholmerich J Andreesen R Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation Blood 2004, 104:889-894. 10.1182/ blood-2003-10-3543 15090455
151. Joosten LA Heinhuis B Abdollahi-Roodsaz S Ferwerda G Lebourhis L Philpott DJ Nahori MA Popa C Morre SA Meer van der JW Girardin SE Netea MG Berg van den WB Differential function of the NACHT-LRR (NLR) members Nod1 and Nod2 in arthritis Proc Natl Acad Sci USA 2008, 105:9017-9022. 10.1073/pnas.0710445105 18574154
152. Pawlik A Kurzawski M Gawronska-Szklarz B Drozdzik M Herczynska M NOD2 allele variants in patients with rheumatoid arthritis Clin Rheumatol 2007, 26:868-871. 10.1007/s10067-006-0404-1 16977346
153. Cummings J Cooney R Clarke G Beckley J Geremia A Cardon L Jewell D The genetics of Nod-like receptors proteins in Crohn's disease J Crohn's Colitis 2008, 2:P191. 10.1016/j.crohns.2008.03.007
154. Barrett JC Hansoul S Nicolae DL Cho JH Duerr RH Rioux JD Brant SR Silverberg MS Taylor KD Barmada MM Bitton A Dassopoulos T Datta LW Green T Griffiths AM Kistner EO Murtha MT Regueiro MD Rotter JI Schumm LP Steinhart AH Targan SR Xavier RJ NIDDK IBD Genetics Consortium Libioulle C Sandor C Lathrop M Belaiche J Dewit O Gut I Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease Nat Genet 2008, 40:955-962. 10.1038/ng.175 18587394
155. Rutgeerts P D'Haens G Targan S Vasiliauskas E Hanauer SB Present DH Mayer L Van Hogezand RA Braakman T DeWoody KL Schaible TF Van Deventer SJ Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease Gastroenterology 1999, 117:761-769. 10.1016/S0016-5085(99)70332-X 10500056
156. Mascheretti S Hampe J Croucher PJ Nikolaus S Andus T Schubert S Olson A Bao W Folsch UR Schreiber S Response to infliximab treatment in Crohn's disease is not associated with mutations in the CARD15 (NOD2) gene: An analysis in 534 patients from two multicenter, prospective GCP-level trials Pharmacogenetics 2002, 12:509-515. 10.1097/ 00008571-200210000-00002 12360101
157. Vermeire S Louis E Rutgeerts P De Vos M Van Gossum A Belaiche J Pescatore P Fiasse R Pelckmans P Vlietinck R Merlin F Zouali H Thomas G Colombel JF Hugot JP Belgian Group of Infliximab Expanded Access Program and Fondation Jean Dausset CEPH, Paris, rance NOD2/CARD15 does not influence response to infliximab in Crohn's disease Gastroenterology 2002, 123:106-111. 10.1053/gast.2002.34172 12105838
158. Carter JD Valeriano J Vasey FB Crohn disease worsened by anakinra administration J Clin Rheumatol 2003, 9:276-277. 10.1097/ 01.RHU.0000081265.06408.e4 17041471
159. Milman N Andersen CB Hansen A van Overeem Hansen T Nielsen FC Fledelius H Ahrens P Nielsen OH Favourable effect of TNF-alpha inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novo CARD15 mutation APMIS 2006, 114:912-919. 10.1111/j.1600-0463.2006.apm_522.x 17207093
160. Aróstegui JI Arnal C Merino R Modesto C Antonia Carballo M Moreno P García-Consuegra J Naranjo A Ramos E de Paz P Rius J Plaza S Yagüe J NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort Arthritis Rheum 2007, 56:3805-3813. 10.1002/art.22966 17968944
161. Giamarellos-Bourboulis EJ Mouktaroudi M Bodar E Ven van der J Kullberg BJ Netea MG Meer van der JW Crystals of monosodium urate monohydrate enhance LPS-induced release of interleukin-1β by mononuclear cells through a caspase-1 mediated process Ann Rheum Dis 2008. 18390571
162. Uehara A Iwashiro A Sato T Yokota S Takada H Antibodies to proteinase 3 prime human monocytic cells via protease-activated receptor-2 and NF-kappaB for Toll-like receptor- and NOD-dependent activation Mol Immunol 2007, 44:3552-3562. 10.1016/j.molimm.2007.03.010 17452051
163. Uehara A Hirabayashi Y Takada H Antibodies to proteinase 3 (PR3-ANCA) prime human oral, lung, and kidney epithelial cells through protease-activated receptor-2 to secrete proinflammatory cytokines upon stimulation with agonists to various Toll-like receptors, NOD1 and NOD2 Clin Vaccine Immunol 2008, 15:1060-1066. 2446640 18495849 10.1128/ CVI.00137-08
164. Matsumoto T Kaneko T Seto M Wada H Kobayashi T Nakatani K Tonomura H Tono Y Ohyabu M Nobori T Shiku H Sudo A Uchida A Kurosawa DJ Kurosawa S The membrane proteinase 3 expression on neutrophils was downregulated after treatment with infliximab in patients with rheumatoid arthritis Clin Appl Thromb Hemost 2008, 14:186-192. 10.1177/1076029607303961 18372277
165. Bhat A Naguwa SM Gershwin ME Genetics and new treatment modalities for familial Mediterranean fever Ann N Y Acad Sci 2007, 1110:201-208. 10.1196/annals.1423.022 17911435
166. Calligaris L Marchetti F Tommasini A Ventura A The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever Eur J Pediatr 2008 167, 695-696. 2292480 17588171 10.1007/ s00431-007-0547-3
167. Chae JJ Wood G Masters SL Richard K Park G Smith BJ Kastner DL The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production Proc Natl Acad Sci USA 2006, 103:9982-9987. 1479864 16785446 10.1073/pnas.0602081103
168. Roldan R Ruiz AM Miranda MD Collantes E Anakinra: New therapeutic approach in children with Familial Mediterranean Fever resistant to colchicine Joint Bone Spine 2008, 75:504-505. 10.1016/ j.jbspin.2008.04.001 18541452
169. Allantaz F Chaussabel D Stichweh D Bennett L Allman W Mejias A Ardura M Chung W Wise C Palucka K Ramilo O Punaro M Banchereau J Pascual V Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade J Exp Med 2007, 204:2131-2144. 2118700 17724127
170. Dierselhuis MP Frenkel J Wulffraat NM Boelens JJ Anakinra for flares of pyogenic arthritis in PAPA syndrome Rheumatology (Oxford) 2005, 44:406-408. 10.1093/rheumatology/keh479 15637033
171. Bodar EJ Hilst van der JC Drenth JP Meer van der JW Simon A Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: Introducing a vaccination provocation model Neth J Med 2005, 63:260-264. 16093577
172. Benezra D Maftzir G Barak V Blood serum interleukin-1 receptor antagonist in pars planitis and ocular Behcet disease Am J Ophthalmol 1997, 123:593-598. 9152064
173. Duzgun N Ayaslioglu E Tutkak H Aydintug OT Cytokine inhibitors: Soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behcet's disease Rheumatol Int 2005, 25:1-5. 10.1007/ s00296-003-0400-6 14600787
174. Imrie FR Dick AD Biologics in the treatment of uveitis Curr Opin Ophthalmol 2007, 18:481-486. 10.1097/ICU.0b013e3282f03d42 18163000
175. Carneiro LA Travassos LH Girardin SE Nod-like receptors in innate immunity and inflammatory diseases Ann Med 2007, 39:581-593. 10.1080/ 07853890701576172 18038361